Food Retail & Distribution

Page 1

CJ Freshway Corp amends stake acquisition of FreshOne NamSeoul Co., LTD

Friday, 24 Oct 2014 05:06am EDT

CJ Freshway Corp:Acquires 56,607 shares of FreshOne NamSeoul Co., LTD, for 10,601,820,878 won.Transaction settlement date of Oct. 24.The company is holding 82.66 stake (68,607 shares) in FreshOne NamSeoul Co., LTD after the acquisition.Previous announcement was on June 30.

Tesco PLC's chairman to step down-Reuters

Thursday, 23 Oct 2014 09:04am EDT

Tesco PLC:The chairman of Tesco, announced his resignation on Thursday-Reuters.

Hawesko Holding AG confirms FY 2014 sales outlook and comments on FY 2014 EBIT and EBIT margin outlook

Thursday, 23 Oct 2014 04:00am EDT

Hawesko Holding AG:Says continues to expect sales increase of 1 pct to 2 pct against previous year (465 million euros) for FY 2014.Says regarding EBIT margin, now assumes that figure will fall within range between 5.1 pct and 5.3 pct (previous year: 4.8 pct).Says according to Board's current estimate, group EBIT is expected on order of 24-25 million euros (previous year: 22.6 million euros), whereby normal course of business is assumed for important pre-Christmas trading period in fourth quarter.FY 2014 EBIT estimate 26.75 million euros - Thomson Reuters I/B/E/S.

Tesco PLC declares interim dividend

Thursday, 23 Oct 2014 02:01am EDT

Tesco PLC:Declares Interim dividend of 1.16 pence per share.Says it will be paid on Dec. 19 to shareholders who are on the Register of members at close of business on Oct. 31.

Premier Foods plc sees FY 2014 trading profit towards the lower end of market expectations

Thursday, 23 Oct 2014 02:01am EDT

Premier Foods plc:Expects FY 2014 trading profit to be towards the lower end of market expectations.

Diplomat Pharmacy Inc's Harvoni (ledipasvir/sofosbuvir) approved for the treatment of chronic hepatitis C, genotype 1 infection in adults

Wednesday, 22 Oct 2014 04:53pm EDT

Diplomat Pharmacy Inc:Says U.S. Food and Drug Administration (FDA) announced Oct. 10, that Gilead Sciences Harvoni (ledipasvir/sofosbuvir) product was approved for the treatment of chronic hepatitis C, genotype 1 infection in adults.Harvoni is the first oral combination therapy approved for the treatment of hepatitis C and is also the first treatment regimen that does not require administration with pegylated interferon or ribavirin.

Cfs Corp, Aeon and WELCIA HOLDINGS announce management integration basic agreement

Wednesday, 22 Oct 2014 02:00am EDT

Cfs Corp:Cfs Corp, Aeon and WELCIA HOLDINGS signed management integration basic agreement on Oct. 22.WELCIA HOLDINGS to acquire Cfs Corp, subsidiary of Aeon through stock swap, with expected effective date on Sep. 1, 2015.

Kesko Oyj to sell store sites; gives guidance for next 12 months

Wednesday, 22 Oct 2014 02:00am EDT

Kesko Oyj:Says is looking into selling some of its store sites to a fund to be set up with Kesko as one of its major investors.Says Kesko's objective is to set up a fund of mainly Kesko-owned store sites and shopping centres in Finland and Sweden with a maximum fair value of about 750 - 950 million euros.Says possible fund is expected to be launched in the course of 2014.Says Kesko Group's net sales and operating profit excluding non-recurring items for the next 12 months are expected to remain at the level of the preceding 12 months.

Axfood comments on FY 2014 profit guidance

Wednesday, 22 Oct 2014 01:30am EDT

Axfood AB:Sees profit for FY 2014 to exceed level achieved in FY 2013.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Bohai Securities Co.,Ltd.
$92.00
Provider: Wright Reports
$75.00
Provider: Wright Reports
$35.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.